{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:49:01Z","timestamp":1788994141426,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Yunnan Provincial Science and Technology Department Science and Technology Plan Project - Basic Research Program","award":["202401AY070001-220"],"award-info":[{"award-number":["202401AY070001-220"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12010-026-05664-3","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:10:54Z","timestamp":1773767454000},"page":"4353-4375","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Knocking Down CDKN2A Enhances the Therapeutic Effects of Metformin and Resveratrol on Diabetic Retinopathy"],"prefix":"10.1007","volume":"198","author":[{"given":"Jinghua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zailin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"5664_CR1","doi-asserted-by":"publisher","first-page":"1077669","DOI":"10.3389\/fendo.2022.1077669","volume":"13","author":"TE Tan","year":"2022","unstructured":"Tan, T. E., & Wong, T. Y. (2022). Diabetic retinopathy: Looking forward to 2030. Front Endocrinol (Lausanne), 13, 1077669.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"5664_CR2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","volume":"128","author":"ZL Teo","year":"2021","unstructured":"Teo, Z. L., et al. (2021). Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology, 128(11), 1580\u20131591.","journal-title":"Ophthalmology"},{"issue":"8","key":"5664_CR3","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/jdi.13480","volume":"12","author":"KY Lin","year":"2021","unstructured":"Lin, K. Y., et al. (2021). Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig, 12(8), 1322\u20131325.","journal-title":"J Diabetes Investig"},{"issue":"12","key":"5664_CR4","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1007\/s00210-023-02599-y","volume":"396","author":"MZ Sadikan","year":"2023","unstructured":"Sadikan, M. Z., Abdul, N. A., & Nasir (2023). Diabetic retinopathy: emerging concepts of current and potential therapy. Naunyn-Schmiedeberg\u2019S Archives Of Pharmacology, 396(12), 3395\u20133406.","journal-title":"Naunyn-Schmiedeberg\u2019S Archives Of Pharmacology"},{"key":"5664_CR5","doi-asserted-by":"crossref","unstructured":"Miller, D. J., Cascio, M. A., & Rosca, M. G. (2020). Diabetic Retinopathy: The Role of Mitochondria in the Neural Retina and Microvascular Disease. Antioxidants (Basel), 9(10), 905.","DOI":"10.3390\/antiox9100905"},{"key":"5664_CR6","doi-asserted-by":"crossref","unstructured":"Andrieux, P. (2021). Mitochondria as a Cellular Hub in Infection and Inflammation. International Journal Of Molecular Sciences, 22(21), 11338.","DOI":"10.3390\/ijms222111338"},{"issue":"2","key":"5664_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41556-021-00837-0","volume":"24","author":"J D\u00f6hla","year":"2022","unstructured":"D\u00f6hla, J., et al. (2022). Metabolic determination of cell fate through selective inheritance of mitochondria. Nature Cell Biology, 24(2), 148\u2013154.","journal-title":"Nature Cell Biology"},{"key":"5664_CR8","doi-asserted-by":"crossref","unstructured":"Li, Y. (2022). GRP75 Modulates Endoplasmic Reticulum-Mitochondria Coupling and Accelerates Ca(2+)-Dependent Endothelial Cell Apoptosis in Diabetic Retinopathy. Biomolecules, 12(12), 1778.","DOI":"10.3390\/biom12121778"},{"issue":"1","key":"5664_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12031-023-02175-2","volume":"74","author":"E Qaed","year":"2024","unstructured":"Qaed, E., et al. (2024). Uncovering the Therapeutic Potential of Phosphocreatine in Diabetic Retinopathy: Mitigating Mitochondrial Dysfunction and Apoptosis via JAK2\/STAT3 Signaling Pathway. Journal Of Molecular Neuroscience, 74(1), 11.","journal-title":"Journal Of Molecular Neuroscience"},{"key":"5664_CR10","doi-asserted-by":"publisher","first-page":"154887","DOI":"10.1016\/j.phymed.2023.154887","volume":"126","author":"X Cheng","year":"2024","unstructured":"Cheng, X., et al. (2024). Quercetin: A promising therapy for diabetic encephalopathy through inhibition of hippocampal ferroptosis. Phytomedicine, 126, 154887.","journal-title":"Phytomedicine"},{"key":"5664_CR11","doi-asserted-by":"publisher","first-page":"1243834","DOI":"10.3389\/fimmu.2023.1243834","volume":"14","author":"M Su","year":"2023","unstructured":"Su, M., et al. (2023). Astragalus improves intestinal barrier function and immunity by acting on intestinal microbiota to treat T2DM: a research review. Frontiers In Immunology, 14, 1243834.","journal-title":"Frontiers In Immunology"},{"key":"5664_CR12","doi-asserted-by":"publisher","first-page":"102786","DOI":"10.1016\/j.redox.2023.102786","volume":"64","author":"P Sekar","year":"2023","unstructured":"Sekar, P., et al. (2023). Metformin inhibits methylglyoxal-induced retinal pigment epithelial cell death and retinopathy via AMPK-dependent mechanisms: Reversing mitochondrial dysfunction and upregulating glyoxalase 1. Redox Biology, 64, 102786.","journal-title":"Redox Biology"},{"issue":"3","key":"5664_CR13","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1007\/s12035-024-04496-8","volume":"62","author":"Y Wang","year":"2025","unstructured":"Wang, Y., et al. (2025). Resveratrol Protects M\u00fcller Cells Against Ferroptosis in the Early Stage of Diabetic Retinopathy by Regulating the Nrf2\/GPx4\/PTGS2 Pathway. Molecular Neurobiology, 62(3), 3412\u20133427.","journal-title":"Molecular Neurobiology"},{"issue":"9","key":"5664_CR14","doi-asserted-by":"publisher","first-page":"e1418","DOI":"10.1002\/ctm2.1418","volume":"13","author":"D Chen","year":"2023","unstructured":"Chen, D., et al. (2023). LncRNA NEAT1 suppresses cellular senescence in hepatocellular carcinoma via KIF11-dependent repression of CDKN2A. Clin Transl Med, 13(9), e1418.","journal-title":"Clin Transl Med"},{"issue":"2","key":"5664_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2337\/db15-0602","volume":"65","author":"A Pal","year":"2016","unstructured":"Pal, A., et al. (2016). Loss-of-Function Mutations in the Cell-Cycle Control Gene CDKN2A Impact on Glucose Homeostasis in Humans. Diabetes, 65(2), 527\u2013533.","journal-title":"Diabetes"},{"issue":"4","key":"5664_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.tem.2015.01.008","volume":"26","author":"SA Hannou","year":"2015","unstructured":"Hannou, S. A., et al. (2015). Functional genomics of the CDKN2A\/B locus in cardiovascular and metabolic disease: what have we learned from GWASs? Trends In Endocrinology And Metabolism, 26(4), 176\u2013184.","journal-title":"Trends In Endocrinology And Metabolism"},{"issue":"8","key":"5664_CR17","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00125-016-3967-7","volume":"59","author":"Y Kong","year":"2016","unstructured":"Kong, Y., et al. (2016). Islet biology, the CDKN2A\/B locus and type 2 diabetes risk. Diabetologia, 59(8), 1579\u20131593.","journal-title":"Diabetologia"},{"issue":"5","key":"5664_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1042\/CS20231698","volume":"138","author":"GH Tesch","year":"2024","unstructured":"Tesch, G. H., et al. (2024). Intervention treatment reducing cellular senescence inhibits tubulointerstitial fibrosis in diabetic mice following acute kidney injury. Clin Sci (Lond), 138(5), 309\u2013326.","journal-title":"Clin Sci (Lond)"},{"issue":"50","key":"5664_CR19","doi-asserted-by":"publisher","first-page":"17310","DOI":"10.1074\/jbc.RA120.012543","volume":"295","author":"Y Deleye","year":"2020","unstructured":"Deleye, Y., et al. (2020). CDKN2A\/p16INK4a suppresses hepatic fatty acid oxidation through the AMPK\u03b12-SIRT1-PPAR\u03b1 signaling pathway. Journal Of Biological Chemistry, 295(50), 17310\u201317322.","journal-title":"Journal Of Biological Chemistry"},{"issue":"4","key":"5664_CR20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/hon.3005","volume":"40","author":"X Wang","year":"2022","unstructured":"Wang, X., et al. (2022). The m6A writer METTL3 and the m6A reader IGF2BP2 regulate cutaneous T-cell lymphomas progression via CDKN2A. Hematological Oncology, 40(4), 567\u2013576.","journal-title":"Hematological Oncology"},{"issue":"3","key":"5664_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1615\/CritRevImmunol.2023052059","volume":"44","author":"J Chen","year":"2024","unstructured":"Chen, J., & Zeng, B. (2024). METTL14-Mediated m6a Modification of CDKN2A Promotes the Development of Retinoblastoma by Inhibiting the p53 Pathway. Critical Reviews In Immunology, 44(3), 89\u201398.","journal-title":"Critical Reviews In Immunology"},{"key":"5664_CR22","doi-asserted-by":"publisher","first-page":"p123694","DOI":"10.1016\/j.lfs.2025.123694","volume":"374","author":"Q Peng","year":"2025","unstructured":"Peng, Q., Zhang, H., & Li, Z. (2025). Methyltransferase-like 16 drives diabetic nephropathy progression via epigenetic suppression of V-set pre-B cell surrogate light chain 3. Life Sciences, 374, p123694.","journal-title":"Life Sciences"},{"issue":"1","key":"5664_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13000-024-01556-4","volume":"19","author":"X Du","year":"2024","unstructured":"Du, X., Wang, Y., & Gao, F. (2024). PSAT1 is upregulated by METTL3 to attenuate high glucose-induced retinal pigment epithelial cell apoptosis and oxidative stress. Diagnostic Pathology, 19(1), 138.","journal-title":"Diagnostic Pathology"},{"issue":"6","key":"5664_CR24","doi-asserted-by":"publisher","first-page":"110498","DOI":"10.1016\/j.ygeno.2022.110498","volume":"114","author":"X Cao","year":"2022","unstructured":"Cao, X., et al. (2022). m6A transferase METTL3 regulates endothelial-mesenchymal transition in diabetic retinopathy via lncRNA SNHG7\/KHSRP\/MKL1 axis. Genomics, 114(6), 110498.","journal-title":"Genomics"},{"key":"5664_CR25","doi-asserted-by":"publisher","first-page":"831660","DOI":"10.3389\/fimmu.2022.831660","volume":"13","author":"L Tang","year":"2022","unstructured":"Tang, L., et al. (2022). Melatonin Maintains Inner Blood-Retinal Barrier by Regulating Microglia via Inhibition of PI3K\/Akt\/Stat3\/NF-\u03baB Signaling Pathways in Experimental Diabetic Retinopathy. Frontiers In Immunology, 13, 831660.","journal-title":"Frontiers In Immunology"},{"issue":"2","key":"5664_CR26","first-page":"203","volume":"22","author":"Z Nazari","year":"2020","unstructured":"Nazari, Z., et al. (2020). In Utero Exposure to Gestational Diabetes Alters DNA Methylation and Gene Expression of CDKN2A\/B in Langerhans Islets of Rat Offspring. Cell J, 22(2), 203\u2013211.","journal-title":"Cell J"},{"issue":"1","key":"5664_CR27","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1186\/s12967-024-05691-w","volume":"22","author":"S Dong","year":"2024","unstructured":"Dong, S., et al. (2024). METTL3-mediated m6A modification of SIRT1 mRNA affects the progression of diabetic cataracts through cellular autophagy and senescence. J Transl Med, 22(1), 865.","journal-title":"J Transl Med"},{"issue":"8","key":"5664_CR28","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1080\/15384101.2023.2170521","volume":"22","author":"CJ Chen","year":"2023","unstructured":"Chen, C. J., et al. (2023). Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4. Cell Cycle, 22(8), 986\u20131004.","journal-title":"Cell Cycle"},{"key":"5664_CR29","doi-asserted-by":"publisher","first-page":"568006","DOI":"10.3389\/fphar.2020.568006","volume":"11","author":"J Wu","year":"2020","unstructured":"Wu, J., et al. (2020). Resveratrol Attenuates High-Fat Diet Induced Hepatic Lipid Homeostasis Disorder and Decreases m(6)A RNA Methylation. Frontiers In Pharmacology, 11, 568006.","journal-title":"Frontiers In Pharmacology"},{"issue":"9","key":"5664_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ng.2383","volume":"44","author":"AP Morris","year":"2012","unstructured":"Morris, A. P., et al. (2012). Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nature Genetics, 44(9), 981\u2013990.","journal-title":"Nature Genetics"},{"issue":"1","key":"5664_CR31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12886-023-03118-6","volume":"23","author":"H Li","year":"2023","unstructured":"Li, H., et al. (2023). Research progress on the pathogenesis of diabetic retinopathy. Bmc Ophthalmology, 23(1), 372.","journal-title":"Bmc Ophthalmology"},{"issue":"4","key":"5664_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s42255-023-00783-1","volume":"5","author":"AS Monzel","year":"2023","unstructured":"Monzel, A. S., Enr\u00edquez, J. A., & Picard, M. (2023). Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction. Nat Metab, 5(4), 546\u2013562.","journal-title":"Nat Metab"},{"key":"5664_CR33","doi-asserted-by":"publisher","first-page":"101205","DOI":"10.1016\/j.preteyeres.2023.101205","volume":"96","author":"JI Jim\u00e9nez-Loygorri","year":"2023","unstructured":"Jim\u00e9nez-Loygorri, J. I., et al. (2023). Mitophagy in the retina: Viewing mitochondrial homeostasis through a new lens. Progress In Retinal And Eye Research, 96, 101205.","journal-title":"Progress In Retinal And Eye Research"},{"key":"5664_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-3-030-66014-7_10","volume":"1256","author":"DA Ferrington","year":"2021","unstructured":"Ferrington, D. A., et al. (2021). Mitochondria: The Retina\u2019s Achilles\u2019 Heel in AMD. Advances In Experimental Medicine And Biology, 1256, 237\u2013264.","journal-title":"Advances In Experimental Medicine And Biology"},{"key":"5664_CR35","doi-asserted-by":"publisher","first-page":"102687","DOI":"10.1016\/j.redox.2023.102687","volume":"62","author":"Z Zeng","year":"2023","unstructured":"Zeng, Z., et al. (2023). Pathologically high intraocular pressure induces mitochondrial dysfunction through Drp1 and leads to retinal ganglion cell PANoptosis in glaucoma. Redox Biology, 62, 102687.","journal-title":"Redox Biology"},{"issue":"26","key":"5664_CR36","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.2174\/09298673113209990029","volume":"20","author":"RA Kowluru","year":"2013","unstructured":"Kowluru, R. A. (2013). Mitochondria damage in the pathogenesis of diabetic retinopathy and in the metabolic memory associated with its continued progression. Current Medicinal Chemistry, 20(26), 3226\u20133233.","journal-title":"Current Medicinal Chemistry"},{"issue":"1","key":"5664_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12967-024-05046-5","volume":"22","author":"B Chen","year":"2024","unstructured":"Chen, B., et al. (2024). WNT-inhibitory factor 1-mediated glycolysis protects photoreceptor cells in diabetic retinopathy. J Transl Med, 22(1), 245.","journal-title":"J Transl Med"},{"key":"5664_CR38","doi-asserted-by":"publisher","first-page":"1160155","DOI":"10.3389\/fendo.2023.1160155","volume":"14","author":"K Alka","year":"2023","unstructured":"Alka, K., Kumar, J., & Kowluru, R. A. (2023). Impaired mitochondrial dynamics and removal of the damaged mitochondria in diabetic retinopathy. Front Endocrinol (Lausanne), 14, 1160155.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5664_CR39","doi-asserted-by":"publisher","first-page":"108616","DOI":"10.1016\/j.exer.2021.108616","volume":"208","author":"N Kumari","year":"2021","unstructured":"Kumari, N., et al. (2021). The potential role of m6A RNA methylation in diabetic retinopathy. Experimental Eye Research, 208, 108616.","journal-title":"Experimental Eye Research"},{"issue":"4","key":"5664_CR40","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.ymthe.2022.01.002","volume":"30","author":"L Jiang","year":"2022","unstructured":"Jiang, L., et al. (2022). METTL3-mediated m(6)A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy. Molecular Therapy, 30(4), 1721\u20131740.","journal-title":"Molecular Therapy"},{"issue":"2","key":"5664_CR41","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ajpath.2024.10.007","volume":"195","author":"N Han","year":"2025","unstructured":"Han, N., Yu, N., & Yu, L. (2025). The mRNA Stability of PIEZO1, Regulated by Methyltransferase-Like 3 via N(6)-Methylation of Adenosine Modification in a YT521-B Homology Domain Family 2-Dependent Manner, Facilitates the Progression of Diabetic Retinopathy. American Journal Of Pathology, 195(2), 265\u2013280.","journal-title":"American Journal Of Pathology"},{"issue":"1","key":"5664_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.7150\/thno.63441","volume":"12","author":"L Suo","year":"2022","unstructured":"Suo, L., et al. (2022). METTL3-mediated N(6)-methyladenosine modification governs pericyte dysfunction during diabetes-induced retinal vascular complication. Theranostics, 12(1), 277\u2013289.","journal-title":"Theranostics"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05664-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05664-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05664-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:36:18Z","timestamp":1779330978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05664-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5664"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05664-3","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"5 March 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental protocols were approved by the Animal Experiment Ethics Review Committee. All animal experiments complied with ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors have no relevant financial or nonfinancial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}]}}